Literature DB >> 25567238

A study on the inhibition of dihydrofolate reductase (DHFR) from Escherichia coli by gold(i) phosphane compounds. X-ray crystal structures of (4,5-dichloro-1H-imidazolate-1-yl)-triphenylphosphane-gold(i) and (4,5-dicyano-1H-imidazolate-1-yl)-triphenylphosphane-gold(i).

Rossana Galassi1, Camille Simon Oumarou, Alfredo Burini, Alessandro Dolmella, Daniela Micozzi, Silvia Vincenzetti, Stefania Pucciarelli.   

Abstract

An unprecedented study on the inhibitory activities of a class of phosphane gold(i) complexes on E. coli dihydrofolate reductase (DHFR) is reported. The gold(i) complexes considered in this work consist of azolate or chloride ligands and phosphane as co-ligands. The ligands have been functionalized with polar groups (-COOH, -COO(-), NO2, Cl, CN) to obtain better solubility in polar media. Neutral, anionic and cationic gold(i) complexes have been tested as DHFR inhibitors by means of a continuous direct spectrophotometric method. X-ray structural characterizations were performed on ((triphenylphosphine)-gold(i)-(4,5-dicyanoimidazolyl-1H-1yl) and on the analog (triphenylphosphine)-gold(i)-(4,5-dichloroimidazolyl-1H-1yl). The inhibition constants obtained from the enzyme tests range from 20 μM to 63 nM (auranofin) and are conducive to promoting these compounds as potential DHFR inhibitors.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25567238     DOI: 10.1039/c4dt01542h

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  4 in total

1.  Synchrotron Characterization of Hexagonal and Cubic Lipidic Phases Loaded with Azolate/Phosphane Gold(I) Compounds: A New Approach to the Uploading of Gold(I)-Based Drugs.

Authors:  Paola Astolfi; Michela Pisani; Elisabetta Giorgini; Barbara Rossi; Alessandro Damin; Francesco Vita; Oriano Francescangeli; Lorenzo Luciani; Rossana Galassi
Journal:  Nanomaterials (Basel)       Date:  2020-09-16       Impact factor: 5.076

2.  Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells.

Authors:  Rossana Galassi; Lorenzo Luciani; Valentina Gambini; Silvia Vincenzetti; Giulio Lupidi; Augusto Amici; Cristina Marchini; Junbiao Wang; Stefania Pucciarelli
Journal:  Front Chem       Date:  2021-01-11       Impact factor: 5.221

Review 3.  Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules.

Authors:  Rossana Galassi; Lorenzo Luciani; Junbiao Wang; Silvia Vincenzetti; Lishan Cui; Augusto Amici; Stefania Pucciarelli; Cristina Marchini
Journal:  Biomolecules       Date:  2022-01-05

4.  A trigonal coordination of Au(I) phosphane complexes stabilized by O-H X (X = Cl-, Br-, I-) interactions.

Authors:  Petra Gründlinger; Cezarina Cela Mardare; Thorsten Wagner; Uwe Monkowius
Journal:  Monatsh Chem       Date:  2021-09-15       Impact factor: 1.451

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.